NCT02435940
Inherited Retinal Degenerative Disease Registry No drug interventions Not Available Not Available recruiting NCT01399515
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa treatment 2 completed NCT04765345
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F No drug interventions Not Available Not Available active_not_recruiting NCT03913130
Extension Study to Study PQ-110-001 (NCT03140969) treatment 1 / 2 terminated NCT06627179
Study to Evaluate Ultevursen in Subjects with Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene treatment 2 not_yet_recruiting NCT05573984
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy No drug interventions Not Available Not Available recruiting NCT02946879
Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65) No drug interventions Not Available Not Available completed NCT06162585
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study No drug interventions Not Available Not Available enrolling_by_invitation NCT02203682
Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy treatment 2 unknown_status NCT01727973
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy treatment 1 / 2 completed NCT04945772
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] No drug interventions treatment 2 completed NCT00811512
Fundus Changes in the Microphthalmy Eyes No drug interventions Not Available Not Available completed NCT03872479
Single Ascending Dose Study in Participants With LCA10 treatment 1 / 2 active_not_recruiting NCT03396042
Natural History Study of CEP290-Related Retinal Degeneration No drug interventions Not Available Not Available completed NCT05176717
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) treatment 2 / 3 terminated NCT05158296
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) treatment 2 / 3 terminated NCT03780257
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene treatment 1 / 2 completed NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene treatment 1 / 2 active_not_recruiting NCT03913143
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) treatment 2 / 3 active_not_recruiting NCT00001732
Screening for Studies on Inherited Eye Diseases No drug interventions Not Available Not Available completed NCT00011817
Evaluation and Treatment of Patients With Inherited Eye Diseases No drug interventions Not Available Not Available completed